NCT00400946 2026-02-13
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Dana-Farber Cancer Institute
Phase 3 Completed
Clinical Trials
1 trialsDrug-Related Side Effects and Adverse Reactions × Dexrazoxane × Other hematologic neoplasm × Clear all